Literature DB >> 28220038

Phosphatase PRL2 promotes AML1-ETO-induced acute myeloid leukemia.

M Kobayashi1, S Chen2, Y Bai3, C Yao4, R Gao1, X-J Sun5, C Mu1, T A Twiggs1, Z-H Yu3, H S Boswell6, M C Yoder1, R Kapur1, J C Mulloy7, Z-Y Zhang3, Y Liu1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28220038      PMCID： PMC5695226          DOI： 10.1038/leu.2017.67

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  16 in total

1.  HemaExplorer: a Web server for easy and fast visualization of gene expression in normal and malignant hematopoiesis.

Authors:  Frederik Otzen Bagger; Nicolas Rapin; Kim Theilgaard-Mönch; Bogumil Kaczkowski; Johan Jendholm; Ole Winther; Bo Porse
Journal:  Blood       Date:  2012-06-28       Impact factor: 22.113

2.  The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells.

Authors:  James C Mulloy; Jörg Cammenga; Karen L MacKenzie; Francisco J Berguido; Malcolm A S Moore; Stephen D Nimer
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

Review 3.  AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches.

Authors:  Megan A Hatlen; Lan Wang; Stephen D Nimer
Journal:  Front Med       Date:  2012-08-09       Impact factor: 4.592

4.  Protein Tyrosine Phosphatase PRL2 Mediates Notch and Kit Signals in Early T Cell Progenitors.

Authors:  Michihiro Kobayashi; Sarah C Nabinger; Yunpeng Bai; Momoko Yoshimoto; Rui Gao; Sisi Chen; Chonghua Yao; Yuanshu Dong; Lujuan Zhang; Sonia Rodriguez; Yumi Yashiro-Ohtani; Warren S Pear; Nadia Carlesso; Mervin C Yoder; Reuben Kapur; Mark H Kaplan; Hugo Daniel Lacorazza; Zhong-Yin Zhang; Yan Liu
Journal:  Stem Cells       Date:  2017-01-19       Impact factor: 6.277

5.  Phosphatase PRL2 promotes oncogenic NOTCH1-Induced T-cell leukemia.

Authors:  M Kobayashi; Y Bai; S Chen; R Gao; C Yao; W Cai; A A Cardoso; J Croop; Z-Y Zhang; Y Liu
Journal:  Leukemia       Date:  2016-12-09       Impact factor: 11.528

6.  AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations.

Authors:  Y Yuan; L Zhou; T Miyamoto; H Iwasaki; N Harakawa; C J Hetherington; S A Burel; E Lagasse; I L Weissman; K Akashi; D E Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

Review 7.  Current treatment of acute myeloid leukemia.

Authors:  Gail J Roboz
Journal:  Curr Opin Oncol       Date:  2012-11       Impact factor: 3.645

Review 8.  Core Binding Factor Acute Myeloid Leukemia: New Prognostic Categories and Therapeutic Opportunities.

Authors:  Chandrima Sinha; Lea C Cunningham; Paul P Liu
Journal:  Semin Hematol       Date:  2015-04-07       Impact factor: 3.851

Review 9.  Phosphatase of regenerating liver in hematopoietic stem cells and hematological malignancies.

Authors:  Michihiro Kobayashi; Sisi Chen; Rui Gao; Yunpeng Bai; Zhong-Yin Zhang; Yan Liu
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis.

Authors:  Xiao-Jian Sun; Zhanxin Wang; Lan Wang; Yanwen Jiang; Nils Kost; T David Soong; Wei-Yi Chen; Zhanyun Tang; Tomoyoshi Nakadai; Olivier Elemento; Wolfgang Fischle; Ari Melnick; Dinshaw J Patel; Stephen D Nimer; Robert G Roeder
Journal:  Nature       Date:  2013-06-30       Impact factor: 49.962
View more
  1 in total

1.  Necdin modulates leukemia-initiating cell quiescence and chemotherapy response.

Authors:  Chonghua Yao; Michihiro Kobayashi; Sisi Chen; Sarah C Nabinger; Rui Gao; Stephen Z Liu; Takashi Asai; Yan Liu
Journal:  Oncotarget       Date:  2017-09-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.